How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
German Centre for Cardiovascular Research · Berlin Institute of Health at Charité - Universitätsmedizin Berlin · +30 more institutions
Abstract
Making a firm diagnosis of chronic heart failure with preserved ejection fraction (HFpEF) remains a challenge. We recommend a new stepwise diagnostic process, the 'HFA-PEFF diagnostic algorithm'. Step 1 (P=Pre-test assessment) is typically performed in the ambulatory setting and includes assessment for HF symptoms and signs, typical clinical demographics (obesity, hypertension, diabetes mellitus, elderly, atrial fibrillation), and diagnostic laboratory tests, electrocardiogram, and echocardiography. In the absence of overt non-cardiac causes of breathlessness, HFpEF can be suspected if there is a normal left ventricular ejection fraction, no significant heart valve disease or cardiac ischaemia, and at least…
Citation impact
- FWCI
- 121.10
- Percentile
- 100%
- References
- 329
Authors
24- BPBurkert PieskeCorresponding
German Centre for Cardiovascular Research, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charité - Universitätsmedizin Berlin
- CTCarsten Tschöpe
German Centre for Cardiovascular Research, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charité - Universitätsmedizin Berlin
- RARudolf A. de Boer
University Medical Center Groningen, University of Groningen
- AGAlan G. Fraser
Cardiff University
- SDStefan D. Anker
Universitätsmedizin Göttingen, German Centre for Cardiovascular Research, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Charité - Universitätsmedizin Berlin
Topics & keywords
- Medicine
- Cardiology
- Internal medicine
- Heart failure
- Ejection fraction
- Heart failure with preserved ejection fraction
- Atrial fibrillation
- Diastole
- Good health and well-being
Funding
- AAmgen
- BSBristol-Myers Squibb
- PPfizer
- AAstraZeneca
- BBayer
- SSanofi
- BSBoston Scientific Corporation
- MMyoKardia
- SSingulex
- RResMed
- IDImpulse Dynamics
- ECEuropean Commission
- BHBayer HealthCare
- DDaiichi-Sankyo
- NONederlandse Organisatie voor Wetenschappelijk OnderzoekAwards: 917.13.350, NWO VIDI, grant 917.13.350
- NNNovo Nordisk
- UMUniversitair Medisch Centrum Groningen
- VPVifor Pharma
- SServier
- SGSphingotec GmbH
- AVAbbott Vascular
- ADAbbott Diagnostics
- MRMedical Research Council
- NMNational Medical Research Council